PHOENIX, Ariz. (CitizenWire) — As a part of Business & Decision’s ongoing focus in the Life Science market, we are delighted to announce a partnership with New Strategies, the creators of “AX for Pharma” an industry leading Enterprise Resource Planning solution for the Pharmaceutical industry. This solution, which is based on Microsoft Dynamics AX, has been designed to address the primary business process needs of a Life Science / Pharmaceutical organization.
The Dynamics AX platform provides a broad functional base to address many types of organizational configurations, size and global complexities. New Strategies has adapted and evolved the Dynamics AX platform to address the industry specific requirements of Pharmaceutical companies.
Sylvain Thauvette, B&D CEO for North America, comments “B&D has 20 years of experience in the Life Science industry and believes the New Strategies solution working with Microsoft Dynamics AX is a winning combination. As a well established provider of enterprise solutions in the Life Science industry, combined with our deep knowledge of the Microsoft Dynamics AX application, this new partnership with New Strategies will ensure we continue to lead the pack.”
The solution works well for all sizes and types of companies. Be it a $30M manufacturer or a $1B producer of pharmaceuticals, the solution has the sophistication and functional breadth to cover the needs. B&D’s extensive experience implementing and validating ERP solutions in the Life Sciences industry also brings a level of assurance that the solution will be implemented effectively.
About Business & Decision:
Business & Decision is an international Consulting and Systems Integration (CSI) company. It is a leader in Business Intelligence (BI) and Customer Relationship Management (CRM), and a major player in e-Business, Enterprise Information Management (EIM), Enterprise Solutions as well as Management Consulting. Business & Decision contributes to the success of customer projects by driving maximum business performance. The company has a reputation for functional and technological expertise and has forged partnerships with all of the key technology vendors.
Located in 19 countries, Business & Decision currently employs more than 2,500 people worldwide.
Additional information is available at www.businessdecision.com .
About New Strategies:
New Strategies, developer of AX for Pharma, is an ISV (Independent Software Vendor) specialized in the development of vertical ERP software solutions based on Microsoft Dynamics AX. AX for Pharma covers the needs of the Life Sciences and Pharmaceutical industry with vertical functionality, including coverage for all Supply Chain and Manufacturing Processes, Advanced Quality Management, Plant Maintenance and compliancy to GMP and CFR 21 Part 11 guidelines and regulations. New Strategies’ development team supports AX for Pharma Certified Resellers like Business & Decision by blending extremely rigorous software development practices with business domain expertise. The software production process is itself supported by cGMP guidelines, guaranteeing that the solution’s quality reaches and surpasses the high level required by the Pharmaceutical Industry.
Additional information is available at www.axforpharma.com .
Copyright © 2011 CitizenWire™ and Neotrope®. CitizenWire is a publication of the Neotrope News Network.